Objective To evaluate the association of intrapartum magnesium sulfate for fetal
neuroprotection (MgSO4-FN) with the delivery room resuscitation and neonatal outcomes of …

Very preterm infants have high rates of neurological impairments and disabilities. These
rates have not diminished as the survival rates have improved. Basic science research …

Background Babies born preterm are at an increased risk of dying in the first weeks of life,
and those who survive have a higher rate of cerebral palsy (CP) compared with babies born …

Background Evidence supports magnesium sulphate (MgSO4) for women at risk of imminent
birth at< 32–34 weeks to reduce the likelihood of cerebral palsy in the child. MAGnesium …

Objective To study the effect of antenatal magnesium sulphate (MgSO4) on cerebral palsy
(CP) in a manner that also provides adequate power for a linked trial sequential analysis …

High-dosage, tocolytic magnesium sulfate (MgSO 4) administered to pregnant women
during preterm labor can be toxic, and sometimes lethal, for their newborns (Cochrane …

Objective: The purpose of this study was to determine whether the use of antenatal
magnesium sulfate prevents adverse outcomes (neonatal intraventricular hemorrhage …

Cerebral palsy (CP) remains the most significant neurological disorder associated with
preterm birth. It disrupts quality of life and places huge cost burdens on society. Antenatal …